Evidence map›Paper›PMID 39126123›Full record

ArticleInternational journal of molecular sciences2024

Correction: Scimeca et al. Microcalcifications Drive Breast Cancer Occurrence and Development by Macrophage-Mediated Epithelial to Mesenchymal Transition.

Manuel Scimeca, Rita Bonfiglio, Erika Menichini, Loredana Albonici, Nicoletta Urbano, Maria Teresa De Caro, Alessandro Mauriello, Orazio Schillaci, Alessandra Gambacurta, Elena Bonanno

Abstract readPublished Erratum
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Manuel ScimecaDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0003-0585-1309
Rita BonfiglioDepartment of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
Erika MenichiniDepartment of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
Loredana AlboniciDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0001-5037-4551
Nicoletta UrbanoNuclear Medicine, Policlinico "Tor Vergata", 00133 Rome, Italy.
Maria Teresa De CaroDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
Alessandro MaurielloDepartment of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0002-7351-5676
Orazio SchillaciDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0002-6176-2805
Alessandra GambacurtaDepartment of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
Elena BonannoDepartment of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID39126123
PMCPMC11311546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.